trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['solid tumor', 'love this', 'pantumor', 't-dxd', 'tdxd']
efficacy and safety of t-dxd in pts with her2-expressing solid tumors: destiny-pantumor02 . i love this trial. shows agnostic feature of tdxd . #asco23 #asco2023 #asco 
A dedicated conference for oncology held under the theme "Access. Educate. Collaborate"